Transcriptome Sequencing Market by Product & Service (Consumables, Instruments, Software & Services), Technology (Bulk RNA-seq, Single-cell RNA-seq, Spatial Transcriptomics, Long-read RNA Sequencing), Application, and End User - Global Forecast to 2035
Description
Transcriptome Sequencing Market Size, Share, Trends, Growth Opportunities & Forecast by Product & Service (Consumables, Instruments, Software & Services), Technology, Application, End User, and Region – Global Forecast (2025- 2035)
According to the research report titled, 'Transcriptome Sequencing Market Size, Share, Trends, Growth Opportunities & Forecast by Product & Service (Consumables, Instruments, Software & Services), Technology, Application, End User, and Region – Global Forecast (2025-2035),' the transcriptome sequencing market is projected to reach $11.8 billion by 2035, at a CAGR of 7.3% during the forecast period 2025–2035. The report provides an in-depth analysis of the global transcriptome sequencing market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by declining sequencing costs and increasing throughput capacity, rising adoption of precision medicine and companion diagnostics, growing demand for single-cell and spatial transcriptomics applications, and increasing investment in drug discovery and biomarker development programs. Moreover, the integration of AI and machine learning in transcriptome data analytics, expanding applications of long-read sequencing for full-length transcript analysis, and increasing use in clinical diagnostics and liquid biopsy applications are expected to support the market's growth.
The key players operating in the transcriptome sequencing market are Illumina, Inc. (USA), Thermo Fisher Scientific Inc. (USA), Pacific Biosciences of California, Inc. (USA), Oxford Nanopore Technologies plc (U.K.), 10x Genomics, Inc. (USA), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (USA), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (USA), Takara Bio Inc. (Japan), Becton, Dickinson and Company (USA), Standard BioTools Inc. (USA), Element Biosciences, Inc. (USA), MGI Tech Co., Ltd. (China), Singular Genomics Systems, Inc. (USA), and others.
The transcriptome sequencing market is segmented by product & service (consumables, instruments, and software & services), technology (bulk RNA-seq, single-cell RNA-seq, spatial transcriptomics, long-read RNA sequencing, and small RNA sequencing), application (drug discovery & development, clinical diagnostics, personalized medicine & companion diagnostics, basic & translational research, agricultural & veterinary research, and other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, clinical diagnostic laboratories, contract research organizations & sequencing service providers, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on product and service, the consumables segment made up the largest part of the transcriptome sequencing market in 2025. This segment's leading position comes from the need to continually purchase reagents and kits for ongoing sequencing operations. Researchers frequently use high-quality reagents in transcriptome studies for both research and clinical purposes. The growth of sequencing applications in pharmaceutical, biotechnology, and academic research sectors also contributes to this dominance. Consumables create a steady revenue stream since they must be restocked for each sequencing experiment, unlike instruments that only require a one-time investment. This segment includes RNA extraction kits, library preparation reagents, sequencing chemistry consumables, quality control materials, and sample preparation supplies. The rising use of NGS-based RNA sequencing, single-cell transcriptomics, and spatial transcriptomics applications is significantly increasing the consumption of reagents for each experiment. New library preparation chemistries, reagent kits compatible with automation, and specialized consumables designed for low-input samples and single-cell applications are expanding opportunities in the market. Key players are consistently introducing innovative consumables to keep up with changing researcher needs. For example, QIAGEN will launch the QIAseq Multimodal DNA/RNA Library Kit in May 2024. This kit allows researchers to prepare both DNA and RNA libraries from a single sample, which improves workflow efficiency and reduces sample requirements.
Based on technology, the bulk RNA-seq segment accounted for the largest share of the transcriptome sequencing market in 2025. Its significant market share comes from the fact that bulk RNA-seq is the most established, standardized, and cost-effective transcriptomic technology available today. It has been widely adopted in academic research, pharmaceutical research and development, and clinical studies due to its reliable workflows, reproducibility, and easier data analysis compared to newer single-cell and spatial technologies. Bulk RNA-seq enables high-throughput gene expression profiling across large sample sets, making it suitable for population-level studies, biomarker discovery, toxicology assessments, and drug response analysis. This technology provides broad transcriptome coverage at a much lower cost than single-cell or spatial methods, making it available to more research institutions and applications. Established protocols, extensive validation data, and well-developed bioinformatics tools support its ongoing dominance, particularly in applications where cellular differences aren’t the main focus or where tissue-level average expression is enough for biological insights.
Based on application, the drug discovery and development segment is expected to account for the largest share of the transcriptome sequencing market in 2025. This segment's leading position comes from the way pharmaceutical and biotechnology companies extensively use RNA sequencing technologies for target identification and validation, biomarker discovery, mechanism-of-action studies, toxicogenomics assessments, and stratification of patients in clinical trials. The technology allows for more accurate gene expression profiling, which helps develop targeted therapies, especially in cancer, neurology, immunology, and rare diseases. Transcriptomic data has become a valuable asset throughout the drug development lifecycle, from early target discovery to late-stage clinical development and post-market monitoring. Companies use RNA sequencing to explore disease biology at the molecular level, identify druggable targets, confirm therapeutic mechanisms, predict drug responses, and group patients for tailored medicine approaches. The integration of transcriptome sequencing into companion diagnostic development, particularly for targeted cancer therapies and immunotherapies, strengthens this segment's market leadership, as regulators increasingly require molecular profiling to aid in treatment selection and patient stratification.
Based on end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the transcriptome sequencing market in 2025. This segment's notable market share is due to the heavy use of transcriptomic data at all stages of drug development, from basic research and target discovery to preclinical development, clinical trials, and post-approval studies. These companies maintain strong in-house genomics capabilities while also working with specialized sequencing service providers for large projects and innovative applications. The pharmaceutical industry's emphasis on precision medicine, targeted therapies, and biomarker-driven development creates a steady demand for advanced transcriptome sequencing solutions. Companies use bulk RNA sequencing for extensive expression studies, single-cell RNA sequencing to understand cellular differences in disease models, spatial transcriptomics to map tumor microenvironments and tissue structure, and long-read sequencing to characterize entire transcript isoforms and fusion events. Combining transcriptomics with other omics datasets allows for thorough molecular characterization that supports drug discovery, patient stratification, biomarker validation, and regulatory applications. Major pharmaceutical companies are also investing heavily in building their own bioinformatics and computational biology capabilities to make the most of transcriptomic data.
An in-depth geographical analysis of the industry offers detailed qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the overall transcriptome sequencing market in 2025. This dominance is due to the region's early adoption of advanced genomic technologies, a strong life sciences ecosystem, ongoing investment in biomedical research, and substantial public and private research funding. The region has a high concentration of pharmaceutical and biotechnology companies, leading academic institutions, and major sequencing technology providers, which collectively drive continuous demand for transcriptome sequencing services and products. The United States leads the world in genomics research infrastructure, with significant funding from organizations like the National Institutes of Health and the National Cancer Institute supporting large genomics projects and population health studies. The region benefits from established regulatory paths for genomic diagnostics, strong protection for intellectual property, advanced healthcare systems that incorporate molecular testing, and active collaborations between academia and industry that speed up the translation of technology from research to clinical applications. North America's concentration of innovators in sequencing technology, such as Illumina, Thermo Fisher Scientific, Pacific Biosciences, and 10x Genomics, ensures early access to cutting-edge platforms and ongoing technological progress.
Key Questions Answered in the Report–
According to the research report titled, 'Transcriptome Sequencing Market Size, Share, Trends, Growth Opportunities & Forecast by Product & Service (Consumables, Instruments, Software & Services), Technology, Application, End User, and Region – Global Forecast (2025-2035),' the transcriptome sequencing market is projected to reach $11.8 billion by 2035, at a CAGR of 7.3% during the forecast period 2025–2035. The report provides an in-depth analysis of the global transcriptome sequencing market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by declining sequencing costs and increasing throughput capacity, rising adoption of precision medicine and companion diagnostics, growing demand for single-cell and spatial transcriptomics applications, and increasing investment in drug discovery and biomarker development programs. Moreover, the integration of AI and machine learning in transcriptome data analytics, expanding applications of long-read sequencing for full-length transcript analysis, and increasing use in clinical diagnostics and liquid biopsy applications are expected to support the market's growth.
The key players operating in the transcriptome sequencing market are Illumina, Inc. (USA), Thermo Fisher Scientific Inc. (USA), Pacific Biosciences of California, Inc. (USA), Oxford Nanopore Technologies plc (U.K.), 10x Genomics, Inc. (USA), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (USA), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (USA), Takara Bio Inc. (Japan), Becton, Dickinson and Company (USA), Standard BioTools Inc. (USA), Element Biosciences, Inc. (USA), MGI Tech Co., Ltd. (China), Singular Genomics Systems, Inc. (USA), and others.
The transcriptome sequencing market is segmented by product & service (consumables, instruments, and software & services), technology (bulk RNA-seq, single-cell RNA-seq, spatial transcriptomics, long-read RNA sequencing, and small RNA sequencing), application (drug discovery & development, clinical diagnostics, personalized medicine & companion diagnostics, basic & translational research, agricultural & veterinary research, and other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, clinical diagnostic laboratories, contract research organizations & sequencing service providers, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on product and service, the consumables segment made up the largest part of the transcriptome sequencing market in 2025. This segment's leading position comes from the need to continually purchase reagents and kits for ongoing sequencing operations. Researchers frequently use high-quality reagents in transcriptome studies for both research and clinical purposes. The growth of sequencing applications in pharmaceutical, biotechnology, and academic research sectors also contributes to this dominance. Consumables create a steady revenue stream since they must be restocked for each sequencing experiment, unlike instruments that only require a one-time investment. This segment includes RNA extraction kits, library preparation reagents, sequencing chemistry consumables, quality control materials, and sample preparation supplies. The rising use of NGS-based RNA sequencing, single-cell transcriptomics, and spatial transcriptomics applications is significantly increasing the consumption of reagents for each experiment. New library preparation chemistries, reagent kits compatible with automation, and specialized consumables designed for low-input samples and single-cell applications are expanding opportunities in the market. Key players are consistently introducing innovative consumables to keep up with changing researcher needs. For example, QIAGEN will launch the QIAseq Multimodal DNA/RNA Library Kit in May 2024. This kit allows researchers to prepare both DNA and RNA libraries from a single sample, which improves workflow efficiency and reduces sample requirements.
Based on technology, the bulk RNA-seq segment accounted for the largest share of the transcriptome sequencing market in 2025. Its significant market share comes from the fact that bulk RNA-seq is the most established, standardized, and cost-effective transcriptomic technology available today. It has been widely adopted in academic research, pharmaceutical research and development, and clinical studies due to its reliable workflows, reproducibility, and easier data analysis compared to newer single-cell and spatial technologies. Bulk RNA-seq enables high-throughput gene expression profiling across large sample sets, making it suitable for population-level studies, biomarker discovery, toxicology assessments, and drug response analysis. This technology provides broad transcriptome coverage at a much lower cost than single-cell or spatial methods, making it available to more research institutions and applications. Established protocols, extensive validation data, and well-developed bioinformatics tools support its ongoing dominance, particularly in applications where cellular differences aren’t the main focus or where tissue-level average expression is enough for biological insights.
Based on application, the drug discovery and development segment is expected to account for the largest share of the transcriptome sequencing market in 2025. This segment's leading position comes from the way pharmaceutical and biotechnology companies extensively use RNA sequencing technologies for target identification and validation, biomarker discovery, mechanism-of-action studies, toxicogenomics assessments, and stratification of patients in clinical trials. The technology allows for more accurate gene expression profiling, which helps develop targeted therapies, especially in cancer, neurology, immunology, and rare diseases. Transcriptomic data has become a valuable asset throughout the drug development lifecycle, from early target discovery to late-stage clinical development and post-market monitoring. Companies use RNA sequencing to explore disease biology at the molecular level, identify druggable targets, confirm therapeutic mechanisms, predict drug responses, and group patients for tailored medicine approaches. The integration of transcriptome sequencing into companion diagnostic development, particularly for targeted cancer therapies and immunotherapies, strengthens this segment's market leadership, as regulators increasingly require molecular profiling to aid in treatment selection and patient stratification.
Based on end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the transcriptome sequencing market in 2025. This segment's notable market share is due to the heavy use of transcriptomic data at all stages of drug development, from basic research and target discovery to preclinical development, clinical trials, and post-approval studies. These companies maintain strong in-house genomics capabilities while also working with specialized sequencing service providers for large projects and innovative applications. The pharmaceutical industry's emphasis on precision medicine, targeted therapies, and biomarker-driven development creates a steady demand for advanced transcriptome sequencing solutions. Companies use bulk RNA sequencing for extensive expression studies, single-cell RNA sequencing to understand cellular differences in disease models, spatial transcriptomics to map tumor microenvironments and tissue structure, and long-read sequencing to characterize entire transcript isoforms and fusion events. Combining transcriptomics with other omics datasets allows for thorough molecular characterization that supports drug discovery, patient stratification, biomarker validation, and regulatory applications. Major pharmaceutical companies are also investing heavily in building their own bioinformatics and computational biology capabilities to make the most of transcriptomic data.
An in-depth geographical analysis of the industry offers detailed qualitative and quantitative insights into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the overall transcriptome sequencing market in 2025. This dominance is due to the region's early adoption of advanced genomic technologies, a strong life sciences ecosystem, ongoing investment in biomedical research, and substantial public and private research funding. The region has a high concentration of pharmaceutical and biotechnology companies, leading academic institutions, and major sequencing technology providers, which collectively drive continuous demand for transcriptome sequencing services and products. The United States leads the world in genomics research infrastructure, with significant funding from organizations like the National Institutes of Health and the National Cancer Institute supporting large genomics projects and population health studies. The region benefits from established regulatory paths for genomic diagnostics, strong protection for intellectual property, advanced healthcare systems that incorporate molecular testing, and active collaborations between academia and industry that speed up the translation of technology from research to clinical applications. North America's concentration of innovators in sequencing technology, such as Illumina, Thermo Fisher Scientific, Pacific Biosciences, and 10x Genomics, ensures early access to cutting-edge platforms and ongoing technological progress.
Key Questions Answered in the Report–
What is the current revenue generated by the transcriptome sequencing market globally?
At what rate is the global transcriptome sequencing demand projected to grow for the next 5–10 years?
What are the historical market sizes and growth rates of the global transcriptome sequencing market?
What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
Which segments in terms of product & service, technology, application, and end user are expected to create major traction for the manufacturers in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the global transcriptome sequencing market?
Who are the major players in the global transcriptome sequencing market? What are their specific product offerings in this market?
What are the recent strategic developments in the global transcriptome sequencing market? What are the impacts of these strategic developments on the market?
Scope of the Report:
Transcriptome Sequencing Market Assessment – by Product & Service
Consumables
Instruments
Software & Services
Transcriptome Sequencing Market Assessment – by Technology
Bulk RNA-seq
Single-cell RNA-seq
Spatial Transcriptomics
Long-read RNA Sequencing
Small RNA Sequencing
Transcriptome Sequencing Market Assessment – by Application
Drug Discovery & Development
Clinical Diagnostics
Personalized Medicine & Companion Diagnostics
Basic & Translational Research
Agricultural & Veterinary Research
Other Applications
Transcriptome Sequencing Market Assessment – by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Diagnostic Laboratories
Contract Research Organizations (CROs) & Sequencing Service Providers
Other End Users
Transcriptome Sequencing Market Assessment – by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa
Table of Contents
311 Pages
- 1 Introduction
- 1.1. Market Definition
- 1.2. Currency & Limitations
- 2 Research Methodology
- 2.1. Research Approach
- 2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
- 2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.2. Bottom-Up Approach
- 2.3.3. Top-Down Approach
- 2.3.4. Growth Forecast
- 2.4. Assumptions For The Study
- 3 Executive Summary
- 4 Market Insights
- 4.1. Overview
- 4.2. Drivers
- 4.2.1. Declining Sequencing Costs And Increasing Throughput Capacity
- 4.2.2. Rising Adoption Of Precision Medicine And Companion Diagnostics
- 4.2.3. Growing Demand For Single-Cell And Spatial Transcriptomics Applications
- 4.2.4. Increasing Investment In Drug Discovery And Biomarker Development Programs
- 4.3. Restraints
- 4.3.1. High Capital Investment For Sequencing Infrastructure
- 4.3.2. Complexity Of Bioinformatics Data Analysis And Interpretation
- 4.4. Opportunities
- 4.4.1. Expansion Of Long-Read Sequencing Technologies For Full-Length Transcript Analysis
- 4.4.2. Integration Of Ai And Machine Learning In Transcriptome Data Analytics
- 4.4.3. Growing Application In Clinical Diagnostics And Liquid Biopsy
- 4.5. Challenges
- 4.5.1. Shortage Of Skilled Bioinformatics Professionals
- 4.5.2. Standardization Issues Across Sequencing Platforms And Workflows
- 4.6. Trends
- 4.6.1. Single-Cell Rna Sequencing Revolutionizing Cellular Heterogeneity Research
- 4.6.2. Spatial Transcriptomics Enabling Tissue-Level Gene Expression Mapping
- 4.6.3. Multi-Omics Integration Combining Transcriptomics With Proteomics And Metabolomics
- 4.7. Supply Chain Analysis
- 5 Global Transcriptome Sequencing Market, By Product & Service
- 5.1. Overview
- 5.2. Consumables
- 5.2.1. Library Preparation Kits
- 5.2.2. Sequencing Reagents & Flow Cells
- 5.2.3. Sample Preparation Kits (Rna Extraction & Purification)
- 5.2.4. Other Consumables
- 5.3. Instruments
- 5.3.1. Short-Read Sequencing Platforms
- 5.3.2. Long-Read Sequencing Platforms
- 5.3.3. Single-Cell Sequencing Systems
- 5.4. Software & Services
- 5.4.1. Bioinformatics Software & Data Analysis Tools
- 5.4.2. Sequencing Services
- 6 Global Transcriptome Sequencing Market, By Technology
- 6.1. Overview
- 6.2. Bulk Rna-Seq
- 6.3. Single-Cell Rna-Seq
- 6.3.1. Droplet-Based Microfluidics
- 6.3.2. Plate-Based Methods
- 6.3.3. Combinatorial Indexing
- 6.4. Spatial Transcriptomics
- 6.5. Long-Read Rna Sequencing
- 6.5.1. Single-Molecule Real-Time (Smrt) Sequencing
- 6.5.2. Nanopore Sequencing
- 6.6. Small Rna Sequencing
- 7 Global Transcriptome Sequencing Market, By Application
- 7.1. Overview
- 7.2. Drug Discovery & Development
- 7.2.1. Target Identification & Validation
- 7.2.2. Biomarker Discovery
- 7.2.3. Toxicogenomics
- 7.3. Clinical Diagnostics
- 7.3.1. Oncology (Tumor Profiling & Liquid Biopsy)
- 7.3.2. Rare & Genetic Diseases
- 7.3.3. Infectious Diseases
- 7.4. Personalized Medicine & Companion Diagnostics
- 7.5. Basic & Translational Research
- 7.6. Agricultural & Veterinary Research
- 7.7. Other Applications
- 8 Global Transcriptome Sequencing Market, By End User
- 8.1. Overview
- 8.2. Pharmaceutical & Biotechnology Companies
- 8.3. Academic & Research Institutes
- 8.4. Clinical Diagnostic Laboratories
- 8.5. Contract Research Organizations (Cros) & Sequencing Service Providers
- 8.6. Other End Users
- 9 Transcriptome Sequencing Market Assessment, By Geography
- 9.1. Overview
- 9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
- 9.3. Europe
- 9.3.1. Germany
- 9.3.2. U.K.
- 9.3.3. France
- 9.3.4. Italy
- 9.3.5. Switzerland
- 9.3.6. Spain
- 9.3.7. Belgium
- 9.3.8. Rest Of Europe
- 9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Australia
- 9.4.5. Rest Of Asia-Pacific
- 9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest Of Latin America
- 9.6. Middle East & Africa
- 9.6.1. Saudi Arabia
- 9.6.2. UAE
- 9.6.3. South Africa
- 9.6.4. Rest Of Middle East & Africa
- 10 Competitive Landscape
- 10.1. Introduction
- 10.2. Key Growth Strategies
- 10.3. Competitive Benchmarking
- 10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
- 11 Company Profiles
- 11.1. Illumina, Inc. (U.S.)
- 11.1.1. Company Overview
- 11.1.2. Financial Overview
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Developments
- 11.2. Thermo Fisher Scientific, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Overview
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Developments
- 11.3. Pacific Biosciences Of California, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Overview
- 11.3.3. Product Portfolio
- 11.3.4. Strategic Developments
- 11.4. Oxford Nanopore Technologies Ltd.
- 11.4.1. Company Overview
- 11.4.2. Product Portfolio
- 11.4.3. Strategic Developments
- 11.5. 10x Genomics, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Overview
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Developments
- 11.6. Qiagen N.V.
- 11.6.1. Company Overview
- 11.6.2. Financial Overview
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Developments
- 11.7. Agilent Technologies, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Overview
- 11.7.3. Product Portfolio
- 11.7.4. Strategic Developments
- 11.8. F. Hoffmann-La Roche Ltd. (U.S.)
- 11.8.1. Company Overview
- 11.8.2. Financial Overview
- 11.8.3. Product Portfolio
- 11.8.4. Strategic Developments
- 11.9. Bio-Rad Laboratories, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Overview
- 11.9.3. Product Portfolio
- 11.9.4. Strategic Developments
- 11.10. Takara Bio Inc. (U.S.)
- 11.10.1. Company Overview
- 11.10.2. Product Portfolio
- 11.10.3. Strategic Developments
- 11.11. Becton, Dickinson And Company (U.S.)
- 11.11.1. Company Overview
- 11.11.2. Financial Overview
- 11.11.3. Product Portfolio
- 11.11.4. Strategic Developments
- 11.12. Standard Biotools Inc. (U.S.)
- 11.12.1. Company Overview
- 11.12.2. Financial Overview
- 11.12.3. Product Portfolio
- 11.12.4. Strategic Developments
- 11.13. Element Biosciences, Inc. (U.S.)
- 11.13.1. Company Overview
- 11.13.2. Product Portfolio
- 11.13.3. Strategic Developments
- 11.14. Mgi Tech Co., Ltd. (China)
- 11.14.1. Company Overview
- 11.14.2. Financial Overview
- 11.14.3. Product Portfolio
- 11.14.4. Strategic Developments
- 11.15. Singular Genomics Systems, Inc. (U.S.)
- 11.15.1. Company Overview
- 11.15.2. Product Portfolio
- 11.15.3. Strategic Developments
- 12 Appendix
- 12.1. Available Customization
- 12.2. Related Reports
- List of Tables
- Table 1 Global Transcriptome Sequencing Market, By Product & Service, 2025-2035 (USD Million)
- Table 2 Global Transcriptome Sequencing Consumables Market, By Type, 2025–2035 (USD Million)
- Table 3 Global Transcriptome Sequencing Consumables Market, By Country/Region, 2023-2035 (USD Million)
- Table 4 Global Transcriptome Sequencing Library Preparation Kits Market, By Country/Region, 2023-2035 (USD Million)
- Table 5 Global Transcriptome Sequencing Sequencing Reagents and Flow Cells Market, By Country/Region, 2023-2035 (USD Million)
- Table 6 Global Transcriptome Sequencing Sample Preparation Kits Market, By Country/Region, 2023-2035 (USD Million)
- Table 7 Global Transcriptome Sequencing Other Consumables Market, By Country/Region, 2023-2035 (USD Million)
- Table 8 Global Transcriptome Sequencing Instruments Market, By Type, 2025–2035 (USD Million)
- Table 9 Global Transcriptome Sequencing Instruments Market, By Country/Region, 2023-2035 (USD Million)
- Table 10 Global Transcriptome Short-Read Sequencing Platforms Market, By Country/Region, 2023-2035 (USD Million)
- Table 11 Global Transcriptome Long-Read Sequencing Platforms Market, By Country/Region, 2023-2035 (USD Million)
- Table 12 Global Transcriptome Single-Cell Sequencing Platforms Market, By Country/Region, 2023-2035 (USD Million)
- Table 13 Global Transcriptome Sequencing Software & Services Market, By Type, 2025–2035 (USD Million)
- Table 14 Global Transcriptome Sequencing Software & Services Market, By Country/Region, 2023-2035 (USD Million)
- Table 15 Global Transcriptome Bioinformatics Software & Data Analysis Tools Market, By Country/Region, 2023-2035 (USD Million)
- Table 16 Global Transcriptome Sequencing Services Market, By Country/Region, 2023-2035 (USD Million)
- Table 17 Global Transcriptome Sequencing Market, By Technology, 2025-2035 (USD Million)
- Table 18 Global Transcriptome Rna-Seq Market, By Country/Region, 2023-2035 (USD Million)
- Table 19 Global Transcriptome Single-Cell Rna-Seq Market, By Type, 2025-2035 (USD Million)
- Table 20 Global Transcriptome Single-Cell Rna-Seq Market, By Country/Region, 2023-2035 (USD Million)
- Table 21 Global Transcriptome Droplet-Based Microfluidics Market, By Country/Region, 2023-2035 (USD Million)
- Table 22 Global Transcriptome Plate-Based Methods Market, By Country/Region, 2023-2035 (USD Million)
- Table 23 Global Transcriptome Combinatorial Indexing Market, By Country/Region, 2023-2035 (USD Million)
- Table 24 Global Transcriptome Spatial Transcriptomics Market, By Country/Region, 2023-2035 (USD Million)
- Table 25 Global Transcriptome Long-Read Rna Sequencing Market, By Type, 2025-2035 (USD Million)
- Table 26 Global Transcriptome Long-Read Rna Sequencing Market, By Country/Region, 2023-2035 (USD Million)
- Table 27 Global Transcriptome Smrt Sequencing Market, By Country/Region, 2023-2035 (USD Million)
- Table 28 Global Transcriptome Nanopore Sequencing Market, By Country/Region, 2023-2035 (USD Million)
- Table 29 Global Transcriptome Small Rna Sequencing Market, By Country/Region, 2023-2035 (USD Million)
- Table 30 Global Transcriptome Sequencing Market, By Application, 2025–2035 (USD Million)
- Table 31 Global Transcriptome Sequencing Market for Drug Discovery and Development, By Type, 2025-2035 (USD Million)
- Table 32 Global Transcriptome Sequencing Market for Drug Discovery and Development, By Country/Region, 2023-2035 (USD Million)
- Table 33 Global Transcriptome Sequencing Market for Target Identification & Validation, By Country/Region, 2023-2035 (USD Million)
- Table 34 Global Transcriptome Sequencing Market for Biomarker Discovery, By Country/Region, 2023-2035 (USD Million)
- Table 35 Global Transcriptome Sequencing Market for Toxicogenomics, By Country/Region, 2023-2035 (USD Million)
- Table 36 Global Transcriptome Sequencing Market for Clinical Diagnostics, By Country/Region, 2023-2035 (USD Million)
- Table 37 Global Transcriptome Sequencing Market for Oncology, By Country/Region, 2023-2035 (USD Million)
- Table 38 Global Transcriptome Sequencing Market for Rare & Genetic Diseases T, By Country/Region, 2023-2035 (USD Million)
- Table 39 Global Transcriptome Sequencing Market for Infectious Diseases, By Country/Region, 2023-2035 (USD Million)
- Table 40 Global Transcriptome Sequencing Market for Personalized Medicine and Companion Diagnostics, By Country/Region, 2023-2035 (USD Million)
- Table 41 Global Transcriptome Sequencing Market for Basic and Translational Research, By Country/Region, 2023-2035 (USD Million)
- Table 42 Global Transcriptome Sequencing Market for Agricultural and Veterinary Research, By Country/Region, 2023-2035 (USD Million)
- Table 43 Global Transcriptome Sequencing Market for Other Applications, By Country/Region, 2023-2035 (USD Million)
- Table 44 Global Transcriptome Sequencing Market, By End User, 2025–2035 (USD Million)
- Table 45 Global Transcriptome Sequencing Market for Pharmaceutical and Biotechnology Companies, By Country/Region, 2023-2035 (USD Million)
- Table 46 Global Transcriptome Sequencing Market for Academic and Research Institutes, By Country/Region, 2023-2035 (USD Million)
- Table 47 Global Transcriptome Sequencing Market for Clinical Diagnostic Laboratories, By Country/Region, 2023-2035 (USD Million)
- Table 48 Global Transcriptome Sequencing Market for Contract Research Organizations (Cros) And Sequencing Service Providers, By Country/Region, 2023-2035 (USD Million)
- Table 49 Global Transcriptome Sequencing Market for Other End Users, By Country/Region, 2023-2035 (USD Million)
- Table 50 North America: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 51 North America: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 52 North America: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 53 North America: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 54 North America: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 55 North America: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 56 North America: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 57 North America: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 58 North America: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 59 North America: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 60 North America: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 61 North America: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 62 U.S.: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 63 U.S.: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 64 U.S.: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 65 U.S.: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 66 U.S.: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 67 U.S.: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 68 U.S.: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million
- Table 69 U.S.: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 70 U.S.: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 71 U.S.: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 72 U.S.: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 73 Canada: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 74 Canada: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 75 Canada: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 76 Canada: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 77 Canada: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 78 Canada: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 79 Canada: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 80 Canada: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 81 Canada: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 82 Canada: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 83 Canada: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 84 Europe: Transcriptome Sequencing Market, By Country, 2023–2035 (USD Million)
- Table 85 Europe: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 86 Europe: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 87 Europe: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 88 Europe: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 89 Europe: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 90 Europe: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 91 Europe: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 92 Europe: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 93 Europe: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 94 Europe: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 95 Europe: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 96 Germany: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 97 Germany: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 98 Germany: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 99 Germany: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 100 Germany: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 101 Germany: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 102 Germany: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 103 Germany: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 104 Germany: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 105 Germany: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 106 Germany: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 107 U.K.: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 108 U.K.: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 109 U.K.: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 110 U.K.: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 111 U.K.: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 112 U.K.: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 113 U.K.: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 114 U.K.: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 115 U.K.: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 116 U.K.: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 117 U.K.: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 118 France: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 119 France: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 120 France: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 121 France: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 122 France: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 123 France: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 124 France: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 125 France: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 126 France: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 127 France: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 128 France: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 129 Italy: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 130 Italy: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 131 Italy: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 132 Italy: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 133 Italy: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 134 Italy: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 135 Italy: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 136 Italy: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 137 Italy: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 138 Italy: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 139 Italy: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 140 Switzerland: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 141 Switzerland: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 142 Switzerland: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 143 Switzerland: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 144 Switzerland: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 145 Switzerland: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 146 Switzerland: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 147 Switzerland: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 148 Switzerland: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 149 Switzerland: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 150 Switzerland: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 151 Spain: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 152 Spain: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 153 Spain: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 154 Spain: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 155 Spain: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 156 Spain: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 157 Spain: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 158 Spain: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 159 Spain: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 160 Spain: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 161 Spain: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 162 Belgium: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 163 Belgium: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 164 Belgium: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 165 Belgium: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 166 Belgium: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 167 Belgium: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 168 Belgium: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 169 Belgium: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 170 Belgium: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 171 Belgium: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 172 Belgium: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 173 Rest of Europe: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 174 Rest of Europe: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 175 Rest of Europe: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 176 Rest of Europe: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 177 Rest of Europe: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 178 Rest of Europe: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 179 Rest of Europe: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 180 Rest of Europe: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 181 Rest of Europe: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 182 Rest of Europe: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 183 Rest of Europe: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 184 Asia-Pacific: Transcriptome Sequencing Market, By Country, 2023–2035 (USD Million)
- Table 185 Asia-Pacific: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 186 Asia-Pacific: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 187 Asia-Pacific: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 188 Asia-Pacific: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 189 Asia-Pacific: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 190 Asia-Pacific: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 191 Asia-Pacific: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 192 Asia-Pacific: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 193 Asia-Pacific: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 194 Asia-Pacific: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 195 Asia-Pacific: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 196 China: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 197 China: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 198 China: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 199 China: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 200 China: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 201 China: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 202 China: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 203 China: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 204 China: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 205 China: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 206 China: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 207 Japan: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 208 Japan: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 209 Japan: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 210 Japan: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 211 Japan: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 212 Japan: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 213 Japan: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 214 Japan: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 215 Japan: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 216 Japan: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
- Table 217 Japan: Transcriptomics Market, By End User, 2023-2035 (USD Million)
- Table 218 India: Transcriptome Sequencing Market, By Product and Services, 2023-2035 (USD Million)
- Table 219 India: Transcriptome Sequencing Consumables Market, By Type, 2023-2035 (USD Million)
- Table 220 India: Transcriptome Sequencing Software and Services Market, By Type, 2023-2035 (USD Million)
- Table 221 India: Transcriptome Sequencing Instruments Market, By Type, 2023-2035 (USD Million)
- Table 222 India: Transcriptome Sequencing Market, By Technology, 2023-2035 (USD Million)
- Table 223 India: Single-Cell Rna-Seq Technology Market, By Type, 2023-2035 (USD Million)
- Table 224 India: Long-Read Rna Sequencing Technology Market, By Type, 2023-2035 (USD Million)
- Table 225 India: Transcriptome Sequencing Market, By Application, 2023-2035 (USD Million)
- Table 226 India: Transcriptome Sequencing Market for Drug Discovery & Development, By Type, 2023-2035 (USD Million)
- Table 227 India: Transcriptome Sequencing Market for Clinical Diagnostics Application, By Type, 2023-2035 (USD Million)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.